VERU Insider Trading
Insider Ownership Percentage: 14.90%
Insider Buying (Last 12 Months): $69,102.84
Insider Selling (Last 12 Months): $250,075.35
Veru Share Price & Price History
Current Price: $0.52
Price Change: ▼ Price Decrease of -0.0141 (-2.62%)
As of 04/28/2025 05:00 PM ET
Veru Insider Trading History
Veru Institutional Trading History
Data available starting January 2016
Veru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). Its marketed products comprise FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections. The company's development program includes enobosarm, a selective androgen receptor modulator for treatment of augment fat loss and to prevent muscle loss in sarcopenic obese and overweight elderly patients; Enobosarm, a selective androgen receptor modulator for the treatment of AR+ ER+ HER2- metastatic breast cancer; and sabizabulin, a microtubule disruptor for the treatment of hospitalized patients with viral lung infection on oxygen support who are at high risk for viral induced ARDS and death. The company was formerly known as The Female Health Company and changed its name to Veru Inc. in July 2017. Veru Inc. was incorporated in 1971 and is headquartered in Miami, Florida.
Read More on Veru
Volume
543,581 shs
Average Volume
1,806,352 shs
Market Capitalization
$76.69 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
Who are the company insiders with the largest holdings of Veru?
Who are the major institutional investors of Veru?
Which institutional investors are buying Veru stock?
During the previous quarter, VERU stock was acquired by institutional investors including:
- Cambridge Investment Research Advisors Inc.
- Oppenheimer & Co. Inc.
- 180 Wealth Advisors LLC
- Weaver Consulting Group
In the previous year, these company insiders have bought Veru stock:
- Mitchell Shuster Steiner (CEO)
- Harry Fisch (Insider)
- Michael L Rankowitz (Director)
Learn More investors buying Veru stock.